Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
ACESION PHARMA ApS
APS
Active
Reklamebeskyttelse
CVR 34083738
Nordre Fasanvej 215, 2000
Frederiksberg
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2011 · 14 years old
16 employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ACESION PHARMA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
-18M
-36M
-53M
-71M
-36M
2020
-38M
-6%
2021
-57M
-50%
2022
-53M
+7%
2023
-57M
-8%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
—
—
—
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-36.311
-37.897
-56.635
-53.020
-57.245
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-36.311
-37.897
-56.635
-53.020
-57.245
Net financials
-617
4.844
-3.530
-2.805
1.311
Profit before tax
-36.928
-33.053
-60.165
-55.824
-55.934
Tax
-5.500
-7.896
-13.385
-12.975
-12.901
Net profit
-31.428
-25.157
-46.780
-42.849
-43.033
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
64.533
33.954
53.191
165.939
116.146
Equity
-20.048
10.344
22.983
130.799
89.642
Long-term debt
43.593
17.692
18.489
14.039
7.762
Short-term debt
40.988
5.919
11.719
21.101
18.742
Total debt
84.581
23.611
30.208
35.140
26.504
Financial ratios
5-year trend
EBITDA-margin
-5724500000.0%
This company
15.8%
Market median
-36231012758% vs market
2020
2024
Soliditetsgrad
77.2%
This company
38.2%
Market median
+102% vs market
2020
2024
Egenkapitalforrentning
-48.0%
This company
18.4%
Market median
-361% vs market
2020
2024
Nettoresultatgrad
-4303300000.0%
This company
8.1%
Market median
-53127160594% vs market
2020
2024
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Gæld/egenkapital
0.30×
This company
0.62×
Market median
+52% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on ACESION PHARMA ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
